Travelan

Commerical Button

What is Travelan®?

Travelan® is a natural product, specifically designed to reduce the risk of infection by Enterotoxigenic E. coli (ETEC), Shigella, Salmonella and other bacteria that cause Travellers’ Diarrhoea.

What is Travellers’ Diarhoea?

Up to 70% of people who travel suffer from travellers’ diarrhoea, according to the Centre for Disease Control & Prevention (CDC).

Travellers’ Diarrhoea is characterised by fever, belly cramps and profuse watery diarrhoea that can last for several days and lead to severe dehydration. Travellers’ Diarrhoea develops as a result of ingesting contaminated food and/or water and is common amongst travellers when visiting countries where they have no naturally developed immunity. Infection with Enterotoxigenic E. coli is the most common cause of Travellers’ Diarrhoea.

Travellers’ Diarrhoea can really ruin the enjoyment of your holiday or the effectiveness of a business trip. The devastating loss of your valuable time, money and memories can be disastrous.

How does Travelan® work?

Travelan®’s active ingredient is hyperimmune bovine colostrum powder, a rich source of antibodies that bind to Enterotoxigenic E. coli in the gastrointestinal tract, preventing them from attaching to the intestinal wall and thereby neutralising their ability to cause travellers’ diarrhoea and its associated symptoms. Hyperimmune colostrum is developed under Immuron's proprietary technology to create high titers of antibodies to a range of E- Coli bacteria that is present in normal colostrum in very small amounts

When do I take Travelan®’s?

Take one Travelan® caplet before every meal. Additional caplets may be taken when increased protection is required, i.e. when snacking between meals or if circumstances suggest an increased risk of infection.

Travelan® should be used as an adjunct to normal travel hygiene practices such as “Boil it, cook it, peel it.”

Has Travelan® been clinically tested?

Yes. Travelan® has undergone clinical testing in randomised, double-blind, placebo-controlled clinical trials.

Clinical trials show Travelan® confers protection of up to 90% against infection with the major strain o E.coli that causes Travellers’ Diarrhoea. In addition, these trials showed a significant reduction in abdominal cramps and stomach pain compared to those who did not receive Travelan®. There were no reported treatment-related side effects.